NAION and PDE5i

E-ISSN： 1743-6109|12|1|139-151

ISSN： 1743-6095

Source： THE JOURNAL OF SEXUAL MEDICINE, Vol.12, Iss.1, 2015-01, pp. : 139-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tadalafil: a long-acting PDE5 inhibitor for the management of erectile dysfunction

By Seftel Allen D

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 185-196

Future Medicine

Access to resources Recommend Favorite

KCa activation enhances PDE5 inhibition efficacy

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 169, Iss. 2, 2013-05 ,pp. : 449-461

John Wiley & Sons Inc

Access to resources Recommend Favorite

A 6 month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erectile dysfunction

By Rubio-Aurioles Eusebio

Current Medical Research and Opinion, Vol. 29, Iss. 6, 2013-06 ,pp. : 695-706

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo Effects of Vardenafil (a PDE-5 Inhibitor) on Corpus Cavernosal Smooth Muscle Relaxation in Diabetic Rabbits

Urologia Internationalis, Vol. 82, Iss. 1, 2009-01 ,pp. : 101-107

Karger

Access to resources Recommend Favorite

Chronic PDE5 Treatment with Glycemic Control for DMED

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 3, 2015-03 ,pp. : 600-610

John Wiley & Sons Inc

Access to resources Recommend Favorite